chimerivax

Vaccineexperimental

Clinical trial activity

10 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
10
Phase 3
2
Phase 4
0

Earliest trial started Apr 1, 2003 (NCT00981175)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • chimerivax
  • chimerivax-je

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00746798Phase 2Oct 1, 2008Sanofi
NCT00617344Phase 2Apr 1, 2008Sanofi
NCT00441259Phase 2Jan 1, 2007Azad University, Dr Atul's Child Hospital, Jaipur, Government Medical College, Baroda, India, Sanofi
NCT00442169Phase 2Dec 1, 2005Sanofi
NCT00314145Phase 3Nov 1, 2005Heart of America Research Institute, Sanofi
NCT00314132Phase 3Oct 1, 2005Sanofi, Vince & Associates
NCT00319592Phase 2May 1, 2005Pharmaceutical Research Associates, Inc. (PRA), Sanofi
NCT00981630Phase 2Nov 1, 2004Sanofi
NCT00982137Phase 2Jul 1, 2004Sanofi
NCT00981175Phase 2Apr 1, 2003Sanofi
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
SanofiFor profit101022003
Azad UniversityAcademic/Hospital1012007
Dr Atul's Child Hospital, JaipurAcademic/Hospital1012007
Government Medical College, Baroda, IndiaAcademic/Hospital1012007
Heart of America Research InstituteAcademic/Hospital1012005
Pharmaceutical Research Associates, Inc. (PRA)For profit1012005
Vince & AssociatesFor profit1012005
7 organizations
Page 1 / 1